Tech Company Financing Transactions

Chondrial Therapeutics Funding Round

Chondrial Therapeutics, based in Bala Cynwyd, received $22.6 million from Deerfield Capital, Indiana University Foundation and private investors.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

150 Monument Rd. 207
Bala Cynwyd, PA 19004
USA

Phone

(844) 511-9056

Website

www.chondrialtherapeutics.com

Email Address

[email protected]

Overview

Chondrial Therapeutics is an emerging biotechnology company focused on the treatment of rare mitochondrial diseases. Chondrial's lead compound is CTI-1601, which the Company is developing as a potential treatment for Friedreich's Ataxia.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Carole Ben-Maimon

        

Chief Scientific Officer

Mark Payne

        

VP - Client Services

David Bettoun

        

VP - Operations

John Berman

        

VP - Regulatory Affairs

Jennifer Johansson

        

Browse more venture capital transactions:

Prev: 2/7/2017: Shelf Engine venture capital transaction
Next: 2/7/2017: Blooom venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on funding rounds that are announced publicly. VC investment data records on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary